Your Unread Messages
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
Bayesian Meta-analysis of Hormone Therapy and Mortality in Younger Postmenopausal Women
American Journal of Medicine, 10/27/09
Salpeter SR et al. – The synthesis of data using Bayesian meta–analysis indicates a reduction in mortality in younger postmenopausal women taking hormone therapy compared with no treatment. This finding should be interpreted taking into account the potential benefits and harms of hormone therapy.
Methods- A comprehensive search from 1966 through January 2008 identified randomized controlled trials of at least 6 month's duration that evaluated hormone therapy in women with mean age <60 years and reported at least one death, and prospective observational cohort studies that evaluated the relative risk of mortality associated with hormone therapy after adjustment for confounding variables.
- The results were synthesized using a hierarchical random–effects Bayesian meta–analysis.
- The pooled results from 19 randomized trials, with 16,000 women (mean age 55 years) followed for 83,000 patient–years, showed a mortality relative risk of 0.73 (95% credible interval 0.52–0.96).
- When data from 8 observational studies were added to the analysis, the resultant relative risk was 0.72 (credible interval 0.62–0.82).
- The posterior probability that hormone therapy reduces total mortality in younger women is almost 1.
Related Articles
Study shows hormone replacement therapy decreases mortality in younger postmenopausal woman
EurekAlert, 10/29/09
Relevance Score: 93%
Issues in postmenopausal hormone therapy: A 3-part CME newsletter series Counseling patients about bioidentical hormone preparations
Sexuality, Reproduction & Menopause, 11/13/09
Relevance Score: 90%
Issues in postmenopausal hormone therapy: depression, endometrial health, and discontinuation
Sexuality, Reproduction & Menopause, 10/09/09
Relevance Score: 90%
Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?
Women's Health, 11/02/09
Relevance Score: 89%
Hormone replacement therapy benefits postmenopausal women
Internet Source, 10/09/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
First-trimester use of paroxetine and congenital heart defects: A population-based case-control study
Birth Defects Research, 11/24/09
Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception
Human Reproduction, 11/24/09
The rationale for mTOR inhibition in epithelial ovarian cancer
Expert Opinion on Investigational Drugs, 11/24/09
Today in Menopausal Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Urinary incontinence and waist circumference in older women
Age and Aging, 11/20/09
Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: Open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate
European Journal of Obstetrics & Gynecology and Reproductive Biology , 11/20/09
Testosterone addition to estrogen therapy - Effects on inflammatory markers for cardiovascular disease
Gynecological Endocrinology, 11/20/09
Sponsor
Article Search
Sponsor


See All


